AstraZeneca/MedImmune Versão em português
The São Paulo Research Foundation (FAPESP) and AstraZeneca/MedImmune signed a cooperation agreement with the purpose of establish the conditions for selection and funding of scientific and technological research involving collaboration between scientists working in public or private research or teaching institutions in the State of São Paulo and/or scientists from the AZ Brasil or MedImmune and its Affiliates.
The research will be selected through publicly announced calls for research proposals,
Financial support for the research selected under this agreement will encompass: up to $400,000.00 USD (four hundred thousand U.S. dollars) from FAPESP and up to $400,000.00 USD (four hundred thousand U.S. dollars) from MedImmune/AZ Brasil (on a combined basis) on an annual basis, up to a maximum total of $4,000,000.00 USD (four million dollars) over the five (5) years duration of this Agreement.
Cooperation agreement - Signed on March 13, 2015 and valid for five years.